Flex Pharma, Inc. develops clinically proven products and treatments for muscle cramps and spasms. In January 2015, Flex Pharma went public (NASDAQ: FLKS).
Location: United States, Massachusetts, Boston
Total raised: $40M
Investors 3
| Date | Name | Website |
| - | Bessemer V... | bvp.com |
| - | EcoR1 Capi... | ecor1cap.c... |
| - | Lightstone... | lightstone... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.09.2014 | - | $40M | - |
Mentions in press and media 6
| Date | Title | Description |
| 04.08.2017 | Big Pharma veterans at Pfizer, AstraZeneca join the great migration to biotech | → Biogen has recruited Anabella Villalobos as its new SVP of biotherapeutic & medicinal sciences. The neurosciences vet was poached from Pfizer, where she was head of medicinal synthesis technologies. → Jean-C... |
| 31.07.2017 | AstraZeneca bags a ‘breakthrough’ for bruised checkpoint drug Imfinzi; Inotek CSO takes the helm at Flex | → Just days after a damaging failure for duvalumab (Imfinzi) in a combination approach to lung cancer, the FDA has designated AstraZeneca’s checkpoint inhibitor as a “breakthrough” product deserving special treatment... |
| 06.06.2017 | Tiny Flex Pharma’s CEO Westphal steps down | Flex Pharma is on the lookout for a new chief after co-founder Christoph Westphal, M.D., Ph.D., is stepping down from his CEO role. Sponsored by Agilent Technologies How would you like to win free bench space at Lab Central for one scientis... |
| 06.06.2017 | Tiny Flex Pharma’s CEO Westphal steps down | Flex Pharma is on the lookout for a new chief after co-founder Christoph Westphal, M.D., Ph.D., is stepping down from his CEO role. In the interim, the thinly trade micro-cap has put its R&D head William McVicar, Ph.D., in charge, while... |
| 09.09.2014 | Flex Pharma Raises $40M in Funding | Flex Pharma, Inc., a Boston MA-based biopharmaceutical company that develops treatments for neuromuscular disorders, raised $40m in funding. Backers included: Longwood Fund Bessemer Venture Partners EcoR1 Capital Jennison Associates LLC (on... |
| 09.09.2014 | Flex Pharma Raises $40M | BOSTON, MA, Biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders, announced today that it has raised $40 million. >> Click here for more funding data on Flex Pharma >> To e... |